Skip to main content
COMPUMEDICS LIMITED logo

COMPUMEDICS LIMITED — Investor Relations & Filings

Ticker · CMP ISIN · AU000000CMP2 ASX Manufacturing
Open in API
Filings indexed 562 across all filing types
Latest filing 2026-04-20 Earnings Release
Country AU Australia
Listing ASX CMP

About COMPUMEDICS LIMITED

https://www.compumedics.com.au

Compumedics Limited specializes in the development, manufacture, and commercialization of diagnostic technology for sleep, brain, and ultrasonic blood-flow monitoring. The company provides a comprehensive suite of hardware and software solutions for polysomnography (PSG), electroencephalography (EEG), and transcranial Doppler (TCD) ultrasound. Its products are utilized by hospitals, clinics, and research institutions worldwide to diagnose and monitor sleep disorders, epilepsy, and various neurological conditions. Compumedics is recognized for its high-performance digital amplifiers and sophisticated signal processing software, which support both clinical diagnostics and advanced neuroscience research. The portfolio includes portable ambulatory devices and integrated laboratory systems designed for precise physiological data acquisition and analysis.

Recent filings

Filing Released Lang Actions
Business Update April 2026 5 pages 382.6KB
Earnings Release Classification · 92% confidence The document is an ASX Release dated 21 April 2026 summarising Compumedics’ current trading performance, FY26 year-to-date results, updated FY26 guidance on revenue and EBITDA, and business highlights. It is not a full annual or interim report but a press release announcing financial results and outlook. This matches the definition of an Earnings Release. 9M 2026
2026-04-20 English
March 2026 Corporate Presentation 22 pages 1.4MB
Investor Presentation Classification · 95% confidence The document is a detailed corporate presentation dated March 2026, focusing on the company's business snapshot, financial performance for H1 FY26, segment performance, and growth drivers. It includes extensive financial data such as sales orders, revenue, EBITDA, and guidance for FY26. The content is typical of an investor presentation, providing strategic insights, market positioning, and financial highlights rather than a formal annual or interim report. There is no indication that this is an official regulatory filing like a 10-K or interim report, nor is it a transcript, audit report, or legal proceeding. The document is too detailed and lengthy to be a simple announcement or report publication notice. Therefore, the best fit is Investor Presentation (IP).
2026-03-24 English
Half Yearly Report and Accounts 26 pages 2.0MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ASX Half-year information 31 December 2025' and includes detailed financial data for the half-year period ending 31 December 2025. It contains comprehensive financial statements such as consolidated statement of profit or loss, statement of financial position, cash flows, notes to the financial statements, directors' report, and auditor's review report. The document references compliance with ASX Listing Rule 4.2A.3 and includes an Appendix 4D, which is typical for interim or half-year reports in Australia. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is a full interim financial report rather than a brief announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-02-24 English
Business Update H1 FY26 6 pages 375.9KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX release dated 25 February 2026, presenting detailed financial and operational results for the first half of fiscal year 2026 (H1 FY26). It includes comprehensive financial metrics such as sales orders, revenue, EBITDA, net profit after tax, operating cash flow, and segment performance. The document also discusses business highlights, geographic performance, growth opportunities, and financial outlook for the full fiscal year 2026. The length of the document (12,859 characters) and the depth of financial data and analysis indicate it is a substantive financial report rather than a brief announcement or presentation. The content aligns with an Interim / Quarterly Report, as it covers a period shorter than a full fiscal year and contains actual financial statements and analysis. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2026-02-24 English
6th & New MEG Order 3 pages 326.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 29 January 2026 announcing a new $4.2 million sales order for Compumedics' MEG system in China. It discusses the sales order, revenue visibility, strategic significance, and company outlook. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is a corporate announcement about a capital sale order and revenue outlook rather than a financial report or earnings release. It fits best as a Capital/Financing Update (CAP) because it updates on a significant sales order impacting future revenue and business growth. The document length is 6817 characters, which is consistent with a detailed announcement but not a full report. Therefore, the classification is CAP with high confidence.
2026-01-28 English
H1 FY25 Update - Record Sales 3 pages 340.9KB
Capital/Financing Update Classification · 90% confidence The document is an ASX release dated 22 January 2026 providing a business update for the first half of fiscal year 2026 (H1 FY26). It includes detailed financial metrics such as sales orders, revenue (unaudited), cost base, profitability, and outlook guidance for the full fiscal year 2026. The document discusses operational performance, strategic initiatives, and financial expectations but does not contain full audited financial statements or comprehensive financial disclosures typical of an Interim/Quarterly Report. It also references that the Appendix 4D (a formal interim report) will be released later around 23 February 2026, indicating this document is a preliminary business update rather than the formal interim report itself. The content is more detailed than a simple earnings release (ER) but does not meet the threshold of a full interim report (IR) with substantive financial statements. It is a business update focusing on financial performance and outlook, which aligns best with the Capital/Financing Update (CAP) category, as it includes funding and financial guidance information. Therefore, the most appropriate classification is CAP with high confidence.
2026-01-21 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.